25/100B40.640
USD
-0.02
(-0.05%)
Market Open
Last updated: · Delayed 15 min
Roivant Sciences free cash flow 2019–2026What is free cash flow (FCF)? Free cash flow is the cash a company's operations bring in minus what it spends on long-term assets (capex): cash left for debt, dividends and buybacks.
Roivant Sciences's free cash flow in Q2 FY2026, the three months to 30 September 2026, was 594.21M USD, against -193.51M USD on the same quarter a year before. Roivant Sciences's free cash flow in fiscal year 2025 was -758.56M USD, against -844.05M USD on the year before.
Last updated 10 Nov 2026 · Next report 5 Feb 2027
Free cash flow
Free cash flow Free cash flow margin
| Fiscal year | Period ending | Free cash flow | Growth | Free cash flow margin | Operating cash flow | Capital expenditure | Free cash flow per share |
|---|---|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | — | — | — | -29.28M | — | — |
| FY2025 | 31 Mar 2026 | -758.56M | — | -9,183.51% | -750.35M | -8.21M | -1.09 |
| FY2024 | 31 Mar 2025 | -844.05M | — | -2,905.21% | -839.45M | -4.60M | -1.16 |
| FY2023 | 31 Mar 2024 | -766.65M | — | -2,343.56% | -765.27M | -1.38M | -0.92 |
| FY2022 | 31 Mar 2023 | -856.08M | — | -2,715.14% | -843.39M | -12.69M | -1.20 |
| FY2021 | 31 Mar 2022 | -695.17M | — | -1,257.40% | -677.73M | -17.44M | -1.04 |
| FY2020 | 31 Mar 2021 | -557.94M | — | -2,344.80% | -552.14M | -5.81M | -0.81 |
| FY2019 | 31 Mar 2020 | -766.75M | — | -1,132.75% | -761.83M | -4.92M | -1.12 |
| Quarter | Period ending | Free cash flow | Growth on a year before | Free cash flow margin | Operating cash flow | Capital expenditure | Free cash flow per share |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 30 Sept 2026 | 594.21M | — | 1,691.89% | 594.42M | -208.00K | 0.82 |
| Q1 FY2026 | 30 Jun 2026 | -263.81M | — | -18,295.01% | -263.40M | -419.00K | -0.37 |
| Q4 FY2025 | 31 Mar 2026 | -165.08M | — | -6,550.75% | -163.82M | -1.26M | -0.20 |
| Q3 FY2025 | 31 Dec 2025 | — | — | — | -196.48M | — | — |
| Q2 FY2025 | 30 Sept 2025 | -193.51M | — | -12,317.76% | -185.66M | -7.85M | -0.28 |
| Q1 FY2025 | 30 Jun 2025 | -208.42M | — | -9,604.52% | -204.38M | -4.04M | -0.31 |
| Q4 FY2024 | 31 Mar 2025 | -173.38M | — | -2,290.30% | -172.57M | -811.00K | -0.25 |
| Q3 FY2024 | 31 Dec 2024 | -209.08M | — | -2,318.45% | -207.25M | -1.83M | -0.29 |
| Q2 FY2024 | 17 Sept 2024 | -267.80M | — | -5,984.40% | -266.81M | -996.00K | -0.36 |
| Q1 FY2024 | 30 Jun 2024 | -193.79M | — | -2,425.46% | -192.83M | -965.00K | -0.25 |
| Q4 FY2023 | 31 Mar 2024 | -108.81M | — | -376.10% | -108.46M | -349.00K | -0.14 |
| Q3 FY2023 | 31 Dec 2023 | -210.81M | — | -1,354.63% | -210.45M | -355.00K | -0.25 |
| Q2 FY2023 | 30 Sept 2023 | -196.70M | — | -5,392.05% | -196.43M | -275.00K | -0.26 |
| Q1 FY2023 | 30 Jun 2023 | -250.34M | — | -1,157.67% | -249.93M | -403.00K | -0.33 |
| Q4 FY2022 | 31 Mar 2023 | -180.71M | — | -660.10% | -179.09M | -1.62M | -0.24 |
| Q3 FY2022 | 31 Dec 2022 | -223.10M | — | -1,308.36% | -222.59M | -508.00K | -0.31 |
Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow
Common questions about Roivant Sciences's free cash flow
Source: Financial Modeling Prep